Among older patients with diabetes, glucagon-like peptide 1 receptor agonists were associated with an increased risk for ...

Purpose A retrospective study to ascertain the management of pellucid marginal corneal degeneration (PMCD). Method and results Sixteen patients (average age 42.6 years) presented with PMCD.

Based on the scientific progress achieved in the past few years, it is possible that patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...

Pentacam and corneal topography were more sensitive to tear film abnormalities when measuring the curvature of the cornea in ...

An Optometrist Is Begging People To Stop This Common Habit ASAP originally appeared on Parade. Parade aims to feature only ...

Macular degeneration is a prevalent eye disorder that typically results in loss of vision in individuals who are 50 years of age and older. Although there isn’t a recognized cure for this ...

This is also called age-related macular degeneration (AMD), as the major risk factor for this is aging. It is an eye disorder characterized by a number of conditions negatively affecting the macula.

Structural changes in the form of change in central corneal thickness and curvature ... effects have protective benefits on age related macular degeneration, optic neuritis due to multiple ...

ABSTRACT: Pellucid marginal degeneration (PMD) is the second-most common noninflammatory corneal degeneration after keratoconus. We report a case of a 42-year-old Saudi male who presented with ...

Steven T. Reed, O.D., President of the American Optometric Association, discusses age-related macular degeneration (AMD), the leading cause of severe vision loss in adults over 50, and the importance ...